Aharon Gil - Oct 30, 2024 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role: Director
Signature: Aharon Gil
Stock symbol: DCTH
Transactions as of: Oct 30, 2024
Transactions value $: $500,000
Form type: 4
Date filed: 11/1/2024, 03:47 PM
Previous filing: May 28, 2024
Next filing: Nov 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DCTH	Tranche B warrants to purchase F-4 Preferred Stock	Options Exercise	$500K	+500		$1,000.00	0	Oct 30, 2024	F-4 PREFERRED STOCK	500	$1,000.00	By Rosalind Advisors, Inc., the advisor to the Rosalind Funds	F1, F2, F3
transaction	DCTH	8% CONVERTIBLE NOTE	Expiration (or cancellation) of long derivative position with value received	$0	0		$0.00	0	Oct 30, 2024	CASH	$1.42M	$0.00	By Rosalind Advisors, Inc., the advisor to the Rosalind Funds	F3, F4, F5

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Immediately exercisable
F2	The Tranche B Warrants expire the earlier of (i) twenty-one (21) days following the date of the Issuer's public announcement of record at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and (ii) March 31, 2026. The Issuer announced on October 17, 2024 that it had recorded at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and therefore such Tranche B Warrants expire on November 7, 2024.
F3	Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein
F4	N/A
F5	Delcath repaid the DELCATH SYSTEM - 8% CONVERTIBLE NOTE in full with cash of $1,423,333.